2021 Ransomware Risk Pulse: Pharmaceutical Manufacturing

Key Findings

• Nearly 10% of pharmaceutical manufacturers are highly susceptible to a ransomware attack
• More than 12% of pharmaceutical industry vendors are likely to incur a ransomware attack
• Almost half of all pharmaceutical companies have more than 1,000 leaked employee credentials exposed on the deep web
• Pharmaceutical companies’ annual cyberattack risk averages $31.1 million
• Medium-sized pharmaceutical companies have the highest susceptibility to ransomware
• Data management vendors pose the most significant annual financial risk ($6.2 million) to pharmaceutical manufacturers
• Software vendors vary the most in terms of estimated financial risk, ranging from $331,000 to $46.1 million annually